NASDAQ (usa) | 6715.56 | -12.11 | -0.18% | |
FTSE 100 (london) | 7487.96 | -5.12 | -0.07% | |
DAX (german) | 13465.51 | 235.94 | 1.78% | |
NIKKEI 225 (japan) | 22420.08 | 408.47 | 1.86% | |
Hang - Seng (hong kong) | 28594.06 | 348.52 | 1.23% |
NIFTY - 50 (india) | ||||
Straits Times (singapore) | 3391.61 | 17.53 | 0.52% | |
KOSPI (korea) | 2556.47 | 33.04 | 1.31% | |
All Ordinaries (australia) | 6005.30 | 28.90 | 0.48% | |
BOVESPA (brazil) | 74092.76 | -215.73 | -0.29% |
MannKind Corporation (NASDAQ: MNKD)
MNKD Technical Analysis
3
As on 9th Jun 2023 MNKD SHARE Price closed @ 4.03 and we RECOMMEND Buy for LONG-TERM with Stoploss of 3.72 & Buy for SHORT-TERM with Stoploss of 3.81 we also expect STOCK to react on Following IMPORTANT LEVELS. |
MNKDSHARE Price
Open | 4.10 | Change | Price | % |
High | 4.11 | 1 Day | -0.09 | -2.18 |
Low | 3.96 | 1 Week | -0.61 | -13.15 |
Close | 4.03 | 1 Month | 0.22 | 5.77 |
Volume | 2627900 | 1 Year | -0.36 | -8.20 |
52 Week High 5.63 | 52 Week Low 2.62 |
NASDAQ USA Most Active Stocks
TSLA | 244.40 | 4.06% |
TTOO | 0.07 | -12.50% |
SOFI | 8.18 | 0.74% |
FFIE | 0.33 | 6.45% |
PONO | 1.72 | 2.38% |
AMD | 124.92 | 3.20% |
IDEX | 0.06 | 0.00% |
NKLA | 0.70 | 14.75% |
AMZN | 123.43 | -0.66% |
AAPL | 180.96 | 0.22% |
NASDAQ USA Top Gainers Stocks
NASDAQ USA Top Losers Stocks
MNKD Daily Charts |
MNKD Intraday Charts |
Whats New @ Bazaartrend |
MNKD Free Analysis |
|
MNKD Important Levels Intraday
RESISTANCE | 4.32 |
RESISTANCE | 4.23 |
RESISTANCE | 4.17 |
RESISTANCE | 4.11 |
SUPPORT | 3.95 |
SUPPORT | 3.89 |
SUPPORT | 3.83 |
SUPPORT | 3.74 |
MNKD Forecast March 2024
4th UP Forecast | 6 |
3rd UP Forecast | 5.37 |
2nd UP Forecast | 4.98 |
1st UP Forecast | 4.59 |
1st DOWN Forecast | 3.47 |
2nd DOWN Forecast | 3.08 |
3rd DOWN Forecast | 2.69 |
4th DOWN Forecast | 2.06 |
MNKD Weekly Forecast
4th UP Forecast | 4.94 |
3rd UP Forecast | 4.65 |
2nd UP Forecast | 4.47 |
1st UP Forecast | 4.29 |
1st DOWN Forecast | 3.77 |
2nd DOWN Forecast | 3.59 |
3rd DOWN Forecast | 3.41 |
4th DOWN Forecast | 3.12 |
MNKD Forecast2024
4th UP Forecast | 10.27 |
3rd UP Forecast | 8.27 |
2nd UP Forecast | 7.03 |
1st UP Forecast | 5.8 |
1st DOWN Forecast | 2.26 |
2nd DOWN Forecast | 1.03 |
3rd DOWN Forecast | -0.21 |
4th DOWN Forecast | -2.21 |
MannKind Corporation ( NASDAQ USA Symbol : MNKD )
Sector : Healthcare And Other Stocks in Same Sector
Sector : Healthcare And Other Stocks in Same Sector
MNKD Other Details
Segment | EQ | |
Market Capital | 1187133312.00 | |
Sector | Healthcare | |
Industry | Biotechnology | |
Offical website | > echo $website ; ?> |
MNKD Address
MNKD Latest News
MNKD Business Profile
MannKind Corporation, a biopharmaceutical company, focuses on the development and commercialization of inhaled therapeutic products for endocrine and orphan lung diseases in the United States. The company offers Afrezza, an inhaled insulin used to improve glycemic control in adults with diabetes. It also promotes Thyquidity used for the treatment of hypothyroidism. The company has a license and collaboration agreement with United Therapeutics Corporation for the development and commercialization of a dry powder formulation of Treprostinil (Tyvaso DPI) used for the treatment of pulmonary arterial hypertension; and Thirona Bio to evaluate the therapeutic potential of TGF-ß inhibitor for the treatment of pulmonary fibrosis. It also has an agreement with NRx Pharmaceuticals to develop a dry powder formulation of ZYESAMI (aviptadil), a synthetic form of human vasoactive intestinal peptide to help protect cells against inflammatory conditions. MannKind Corporation was incorporated in 1991 and is headquartered in Westlake Village, California. Address: 30930 Russell Ranch Road, Westlake Village, CA, United States, 91362
© 2005-2023 BazaarTrend.com All rights reserved.
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service